View in EDS

Nanoporous Anodized Alumina for Drug Delivery: Design Strategies and Doxorubicin Release Mechanisms.

Saved in:
Bibliographic Details
Title: Nanoporous Anodized Alumina for Drug Delivery: Design Strategies and Doxorubicin Release Mechanisms.
Authors: Wang, Ao1,2 (AUTHOR), Yang, Shumin2 (AUTHOR), Lin, Xuemei2 (AUTHOR), Qi, Yunkai2 (AUTHOR), Shi, Guochao3 (AUTHOR), Yusop, Abdul Hakim Md1 (AUTHOR), Yajid, Muhamad Azizi Mat1 (AUTHOR), Gu, Jianjun2 (AUTHOR) jjungu@126.com, Ali, Wan Fahmin Faiz Wan1 (AUTHOR) wan_fahmin@utm.my
Source: NANO (1793-2920). Jul2026, Vol. 21 Issue 9, p1-16. 16p.
Subjects: Doxorubicin, Nanoporous materials, Pharmaceutical encapsulation, Anodic oxidation of metals, Drug delivery systems, Pore size distribution, Controlled release drugs, Osteosarcoma
Abstract: This study employed an improved anodization process to fabricate nanoporous anodic alumina (NAA) films with various pore parameters for use as drug carriers. Doxorubicin (DOX) was selected as a model drug to investigate drug loading and in vitro release behaviors. The experimental results demonstrated that pore size and morphology significantly influenced the release rate and diffusion behavior of DOX. Specifically, the design of nonstandard pores from top to bottom is 1 2 1. 2 7 ± 1 1. 5 3 nm, 1 5 9. 2 9 ± 2 3. 5 9 nm, and 1 7 9. 3 4 ± 2 1. 1 0 nm, respectively, which can effectively extend the release duration and enhance diffusion performance. Optimizing the pore structure notably improved the drug-loading capacity and controlled-release performance of the NAA. The DOX release kinetics indicated that the NAA-based drug delivery system (DDS) followed a first-order kinetic model. These findings provide a quantitative framework for tuning release behavior through structural design, which may inform the future development of porous platforms for controlled drug delivery. This study has significant implications for the clinical application of intelligent DDSs that utilize NAA as a drug carrier. In this study, funnel-shaped nanoporous anodized aluminum (NAA) membranes with tailored pore sizes (121, 159, and 179 nm) were fabricated using an optimized anodization process. Their efficacy as doxorubicin (DOX) carriers was evaluated, demonstrating that the refined pore architecture significantly enhances drug loading capacity and controlled release kinetics, offering a promising approach for targeted osteosarcoma therapy. [ABSTRACT FROM AUTHOR]
Copyright of NANO (1793-2920) is the property of World Scientific Publishing Company and its content may not be copied or emailed to multiple sites without the copyright holder's express written permission. Additionally, content may not be used with any artificial intelligence tools or machine learning technologies. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)
Database: Engineering Source
Description
Abstract:This study employed an improved anodization process to fabricate nanoporous anodic alumina (NAA) films with various pore parameters for use as drug carriers. Doxorubicin (DOX) was selected as a model drug to investigate drug loading and in vitro release behaviors. The experimental results demonstrated that pore size and morphology significantly influenced the release rate and diffusion behavior of DOX. Specifically, the design of nonstandard pores from top to bottom is 1 2 1. 2 7 ± 1 1. 5 3 nm, 1 5 9. 2 9 ± 2 3. 5 9 nm, and 1 7 9. 3 4 ± 2 1. 1 0 nm, respectively, which can effectively extend the release duration and enhance diffusion performance. Optimizing the pore structure notably improved the drug-loading capacity and controlled-release performance of the NAA. The DOX release kinetics indicated that the NAA-based drug delivery system (DDS) followed a first-order kinetic model. These findings provide a quantitative framework for tuning release behavior through structural design, which may inform the future development of porous platforms for controlled drug delivery. This study has significant implications for the clinical application of intelligent DDSs that utilize NAA as a drug carrier. In this study, funnel-shaped nanoporous anodized aluminum (NAA) membranes with tailored pore sizes (121, 159, and 179 nm) were fabricated using an optimized anodization process. Their efficacy as doxorubicin (DOX) carriers was evaluated, demonstrating that the refined pore architecture significantly enhances drug loading capacity and controlled release kinetics, offering a promising approach for targeted osteosarcoma therapy. [ABSTRACT FROM AUTHOR]
ISSN:17932920
DOI:10.1142/S1793292025501218